Implementing an electronic end-of-life chemotherapy utilization measure

March 19, 2020

Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ. Journal of Oncology Practice. .

http://ascopubs.org/doi/abs/10.1200/JOP.18.00408

Authors:
Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ

Sources:
Journal of Oncology Practice

Read the research

Posted in

Treatment and Testing patterns

More publications

October 2026

Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancer

May 2026

Real-world treatment patterns and outcomes among patients with high-risk and very high-risk non-metastatic prostate cancer